Bank of New York Mellon’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
24,981
+4,044
| +19% | +$42K | ﹤0.01% | 3850 |
|
|
2025
Q1 | $276K | Buy |
20,937
+1,530
| +8% | +$20.2K | ﹤0.01% | 3720 |
|
|
2024
Q4 | $348K | Buy |
19,407
+4,305
| +29% | +$77.1K | ﹤0.01% | 3678 |
|
|
2024
Q3 | $243K | Sell |
15,102
-4,814
| -24% | -$77.6K | ﹤0.01% | 3837 |
|
|
2024
Q2 | $538K | Buy |
19,916
+9,339
| +88% | +$252K | ﹤0.01% | 3539 |
|
|
2024
Q1 | $206K | Sell |
10,577
-565
| -5% | -$11K | ﹤0.01% | 3915 |
|
|
2023
Q4 | $230K | Sell |
11,142
-8,557
| -43% | -$177K | ﹤0.01% | 3904 |
|
|
2023
Q3 | $626K | Buy |
19,699
+374
| +2% | +$11.9K | ﹤0.01% | 3422 |
|
|
2023
Q2 | $649K | Buy |
19,325
+9,615
| +99% | +$323K | ﹤0.01% | 3446 |
|
|
2023
Q1 | $405K | Sell |
9,710
-2,316
| -19% | -$96.6K | ﹤0.01% | 3599 |
|
|
2022
Q4 | $408K | Buy |
12,026
+9,560
| +388% | +$324K | ﹤0.01% | 3653 |
|
|
2022
Q3 | $121K | Buy |
2,466
+1,216
| +97% | +$59.7K | ﹤0.01% | 4160 |
|
|
2022
Q2 | $49K | Sell |
1,250
-8,352
| -87% | -$327K | ﹤0.01% | 4345 |
|
|
2022
Q1 | $354K | Sell |
9,602
-221
| -2% | -$8.15K | ﹤0.01% | 3911 |
|
|
2021
Q4 | $961K | Buy |
9,823
+247
| +3% | +$24.2K | ﹤0.01% | 3404 |
|
|
2021
Q3 | $1.2M | Buy |
9,576
+998
| +12% | +$125K | ﹤0.01% | 3293 |
|
|
2021
Q2 | $1.08M | Buy |
8,578
+2,018
| +31% | +$253K | ﹤0.01% | 3360 |
|
|
2021
Q1 | $891K | Sell |
6,560
-759
| -10% | -$103K | ﹤0.01% | 3395 |
|
|
2020
Q4 | $665K | Buy |
7,319
+487
| +7% | +$44.2K | ﹤0.01% | 3470 |
|
|
2020
Q3 | $509K | Buy |
6,832
+667
| +11% | +$49.7K | ﹤0.01% | 3486 |
|
|
2020
Q2 | $525K | Buy |
+6,165
| New | +$525K | ﹤0.01% | 3444 |
|
|
2019
Q2 | – | Sell |
-2,870
| Closed | -$204K | – | 4259 |
|
|
2019
Q1 | $204K | Buy |
2,870
+1,143
| +66% | +$81.2K | ﹤0.01% | 3876 |
|
|
2018
Q4 | $138K | Buy |
1,727
+5
| +0.3% | +$400 | ﹤0.01% | 3912 |
|
|
2018
Q3 | $804K | Buy |
1,722
+146
| +9% | +$68.2K | ﹤0.01% | 3390 |
|
|
2018
Q2 | $626K | Buy |
1,576
+337
| +27% | +$134K | ﹤0.01% | 3513 |
|
|
2018
Q1 | $379K | Sell |
1,239
-1
| -0.1% | -$306 | ﹤0.01% | 3693 |
|
|
2017
Q4 | $365K | Sell |
1,240
-127
| -9% | -$37.4K | ﹤0.01% | 3730 |
|
|
2017
Q3 | $748K | Buy |
1,367
+287
| +27% | +$157K | ﹤0.01% | 3381 |
|
|
2017
Q2 | $644K | Buy |
1,080
+589
| +120% | +$351K | ﹤0.01% | 3481 |
|
|
2017
Q1 | $211K | Buy |
+491
| New | +$211K | ﹤0.01% | 3861 |
|